ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 13, 2002

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007